i
Lung Cancer Incidence, 2019–2020, United States: The Potential Impact of the COVID-19 Pandemic
-
10 2024
-
-
Source: Ann Epidemiol. 98:44-50
[PDF-428.71 KB]
Details:
-
Alternative Title:Ann Epidemiol
-
Personal Author:
-
Description:Purpose:
Cancer incidence declined during the COVID-19 pandemic in part due to health care delivery challenges. We examined the impact of the COVID-19 pandemic on changes in lung cancer incidence.
Methods:
We used 2019–2020 US Cancer Statistics data from 49 cancer registries covering 97% of the US population. We calculated the number of new lung cancer diagnoses in 2019 and 2020, age-adjusted lung cancer incidence rates per 100,000 persons, and 2019-to-2020 percentage changes in incidence rates. We also calculated number and percentage of new lung cancer diagnoses by month and stage at diagnosis.
Results:
The age-adjusted lung cancer incidence rate per 100,000 persons was 47.9 in 2019 vs. 41.4 in 2020—a 13.6% decrease. Differences in the percentage change in incidence rates were observed by age, race and ethnicity, US census region, histology, and stage at diagnosis. A higher percentage of people were diagnosed at distant stage in 2020 than 2019.
Conclusions:
This report provides new insight into subgroups that experienced the greatest decline in observed lung cancer incidence during the first year of the COVID-19 pandemic. The findings can be used to inform intervention efforts to improve lung cancer screening, diagnosis, and treatment.
-
Subjects:
-
Keywords:
-
Source:
-
Pubmed ID:39197807
-
Pubmed Central ID:PMC11387122
-
Document Type:
-
Funding:
-
Volume:98
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type:
